HIV Fourth Generation assay upgrade
Posted on October 13, 2016 by ExamOne
As a leader in the life insurance industry, we are committed to ensuring our clients are using the most current and accurate laboratory testing equipment and methodologies. Quest Diagnostics, a leader in diagnostic testing, is passionate about developing innovative, groundbreaking tests, products, and tools to provide value to clients.
Earlier this year we announced we would be converting to the HIV-1/2 Antigen and Antibodies, Fourth Generation assay. Our goal was to convert to this U.S. Centers for Disease Control and Prevention preferred assay by August 1. However, due to some U.S. State Department of Insurance regulations still referencing “Western Blot” testing, we need additional time to prepare. Our new effective date for the HIV 4th Generation assay is November 14.
Additionally, we will be in compliance with provinces still requiring 3rd Generation tests (Western Blot) until we are notified of an updated language change on their regulations.
We appreciate your continued partnership and are committed to providing you with reliable and up-to-date testing for your applicants.
If you have further questions, please contact your Strategic Account Executive.